Northport Medicaid providers billed a total of $570,652 for Pathology and Laboratory Procedures services in 2024, according to data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. This represents a 141.6% jump from 2023, when $236,187 in claims were submitted for the same category.
Medicaid operates as a public health insurance initiative managed by states and financed through both federal and state contributions. It serves low-income residents, older adults, children, and people with disabilities, making it a key element of the nation’s health care system.
Since taxpayers fund Medicaid, shifts in local billing amounts show how health care funding is distributed within a community.
The “Pathology and Laboratory Procedures” category includes an array of Medicaid services grouped by type, based on specific HCPCS and CPT code prefixes and numeric ranges. For this review, billing codes were assigned to just one service category to enable consistent analysis, prevent double counting, and maintain accurate rankings over time.
Pathology and Laboratory Procedures ranked as Northport’s fourth-largest category by Medicaid spending in 2024, despite increases in several other service groups.
Statewide in Alabama, Pathology and Laboratory Procedures was the third-highest Medicaid payment category in 2024.
From 5 years leading up to 2024, Northport Medicaid payments for Pathology and Laboratory Procedures rose by $505,538, a 776.4% increase. Accelerated spending was observed in key years, with substantial annual growth noted in both 2023 and 2022.
While payments for this category were distributed across Northport, the majority were concentrated in a small number of ZIP codes. In 2024, ZIP code 35476 accounted for $561,731 and 35473 for $8,921, making up 100% of category payments in the city for the year.
Payments for Pathology and Laboratory Procedures were primarily focused on a small set of individual billing codes within the category.
To compare, Northport saw a 141.6% rise in Medicaid payments for Pathology and Laboratory Procedures from 2023 to 2024, against a 2.7% overall increase across all Medicaid claim categories during the same span.
The Centers for Medicare & Medicaid Services reports that combined federal and state Medicaid spending reached approximately $871.7 billion in fiscal 2023, making up around 18% of national health expenditures—an increase from about $613.5 billion in 2019, before the COVID-19 pandemic.
This growth of roughly 40% over a few years is largely attributed to higher enrollment and greater service use during and following the pandemic.
Recent federal budget measures under the Trump administration included proposals aimed at reducing federal Medicaid funding and restructuring the program. For instance, the “One Big Beautiful Bill Act,” signed into law in 2025, is expected to slash federal Medicaid spending by over $1 trillion across the next decade. The law introduces provisions like work requirements and higher cost-sharing, which could reduce coverage and funding for certain groups. These modifications may result in greater cost shifts to individual states and slower federal funding growth, while Medicaid continues to serve millions nationwide.
| Year | Total Medicaid Payments | % Change From Previous Year |
|---|---|---|
| 2020 | $65,114 | 9.4% |
| 2021 | $63,317 | -2.8% |
| 2022 | $100,849 | 59.3% |
| 2023 | $236,187 | 134.2% |
| 2024 | $570,652 | 141.6% |
| Rank | Category | Medicaid Payments | Share of City Total |
|---|---|---|---|
| 1 | Evaluation and Management | $1,249,731 | 34.4% |
| 2 | National Codes Established for State Medicaid Agencies | $981,933 | 27.1% |
| 3 | Medicine Services and Procedures | $740,808 | 20.4% |
| 4 | Pathology and Laboratory Procedures | $570,652 | 15.7% |
| 5 | Vision Services | $27,171 | 0.7% |
| 6 | Radiology Procedures | $19,511 | 0.5% |
| 7 | Anesthesia | $13,940 | 0.4% |
| 8 | Surgery | $10,574 | 0.3% |
| 9 | Drugs Administered Other than Oral Method | $9,052 | 0.2% |
| 10 | Durable Medical Equipment | $4,696 | 0.1% |
| 11 | Temporary National Codes (Non-Medicare) | $660 | <0.1% |
| 12 | Medical And Surgical Supplies | $15 | <0.1% |
| 13 | Procedures / Professional Services | $0 | <0.1% |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87633 | Resp virus 12-25 targets | $227,655 | 32 |
| 87635 | Sars-cov-2 covid-19 amp prb | $51,561 | 32 |
| 87634 | Rsv dna/rna amp probe | $43,213 | 22 |
| 87502 | Influenza dna amp probe | $41,900 | 22 |
| 87651 | Strep a dna amp probe | $25,942 | 22 |
| 87581 | M.pneumon dna amp probe | $23,755 | 22 |
| 87486 | Chlmyd pneum dna amp probe | $23,740 | 22 |
| 87640 | Staph a dna amp probe | $22,531 | 22 |
| 87641 | Mr-staph dna amp probe | $20,700 | 22 |
| 87498 | Enterovirus probe&revrs trns | $19,558 | 22 |
| 87804 | Influenza assay w/optic | $11,574 | 24 |
| 87798 | Detect agent nos dna amp | $10,472 | 1 |
| 87880 | Strep a assay w/optic | $8,989 | 30 |
| 87426 | Sarscov coronavirus ag ia | $7,998 | 14 |
| 87801 | Detect agnt mult dna ampli | $5,880 | 3 |
| 83655 | Assay of lead | $3,930 | 13 |
| 85025 | Complete cbc w/auto diff wbc | $3,797 | 25 |
| 83970 | Assay of parathormone | $2,835 | 11 |
| 80061 | Lipid panel | $2,442 | 12 |
| 85018 | Hemoglobin | $2,386 | 76 |
Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.
Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.


